Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026)
Alphatec Holdings' (ATEC) quarterly Cash from Investing Activities came in at -$19.9 million in Q1 2026, down 71.32% year-on-year from -$69.4 million in Q1 2025, and down 26.43% quarter-over-quarter from -$15.7 million in Q4 2025.
Alphatec Holdings (ATEC) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$19.9 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$19.9 million, down 71.32% year-over-year; the trailing twelve-month figure through Mar 2026 was -$61.7 million (up 13.27% YoY), and the FY2025 annual result was -$53.4 million, up 42.65% from the prior year.
- Cash from Investing Activities came in at -$19.9 million for Q1 2026 at Alphatec Holdings, down from -$15.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$3.7 million in Q4 2024 to a low of -$75.6 million in Q2 2023.
- The 5-year median for Cash from Investing Activities is -$15.7 million (2025), against an average of -$21.6 million.
- Across the five-year window, Cash from Investing Activities sank 424.38% in 2023 and surged 86.72% in 2024, its largest moves.
- Alphatec Holdings' Cash from Investing Activities stood at -$14.8 million in 2022, then plunged by 90.18% to -$28.2 million in 2023, then soared by 86.72% to -$3.7 million in 2024, then plunged by 320.05% to -$15.7 million in 2025, then decreased by 26.43% to -$19.9 million in 2026.
- The last three Cash from Investing Activities figures came in at -$19.9 million (Q1 2026), -$15.7 million (Q4 2025), and -$13.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Alphatec Holdings | 1.34 Bn | 1.20 Bn | 136.48 Mn | -19.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.89 Mn |
| Mar 31, 2026 | -19.89 Mn |
| Dec 31, 2025 | -15.74 Mn |
| Dec 31, 2025 | -15.74 Mn |
| Sep 30, 2025 | -13.89 Mn |
| Sep 30, 2025 | -13.89 Mn |
| Jun 30, 2025 | -12.17 Mn |
| Jun 30, 2025 | -12.17 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Mar 31, 2025 | -11.61 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Sep 30, 2024 | -19.88 Mn |
| Sep 30, 2024 | -19.88 Mn |
| Jun 30, 2024 | -35.89 Mn |
| Jun 30, 2024 | -35.89 Mn |
| Mar 31, 2024 | -33.62 Mn |
| Mar 31, 2024 | -33.62 Mn |
| Dec 31, 2023 | -28.21 Mn |
| Dec 31, 2023 | -28.21 Mn |